» Articles » PMID: 35294321

Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary fibrosis is a disease process associated with significant morbidity and mortality, with limited therapeutic options owing to an incomplete understanding of the underlying pathophysiology. Mechanisms driving the fibrotic cascade have been elucidated through studies of rare and common variants in surfactant-related and telomere-related genes in familial and sporadic forms of pulmonary fibrosis, as well as in multisystem Mendelian genetic disorders that present with pulmonary fibrosis. In this translational review, we outline insights into the pathophysiology of pulmonary fibrosis derived from genetic forms of the disease, with a focus on model systems, shared cellular and molecular mechanisms, and potential targets for therapy.

Citing Articles

Human respiratory airway progenitors derived from pluripotent cells generate alveolar epithelial cells and model pulmonary fibrosis.

Pezet M, Torres J, Thimraj T, Matkovic I, Schrode N, Murray J Nat Biotechnol. 2025; .

PMID: 39994483 DOI: 10.1038/s41587-025-02569-0.


Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice.

Predella C, Lapsley L, Ni K, Murray J, Liu H, Motelow J Res Sq. 2024; .

PMID: 39315275 PMC: 11419168. DOI: 10.21203/rs.3.rs-4673915/v1.


Biomechanical Properties and Cellular Responses in Pulmonary Fibrosis.

He A, He L, Chen T, Li X, Cao C Bioengineering (Basel). 2024; 11(8).

PMID: 39199705 PMC: 11351367. DOI: 10.3390/bioengineering11080747.


Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis.

Desroziers T, Prevot G, Coulomb A, Nau V, Dastot-Le Moal F, Duquesnoy P Eur J Hum Genet. 2023; 31(9):1083-1087.

PMID: 37380697 PMC: 10474257. DOI: 10.1038/s41431-023-01413-w.


Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants.

Moss B, Rosas I Am J Respir Crit Care Med. 2023; 207(9):1118-1120.

PMID: 36796091 PMC: 10161759. DOI: 10.1164/rccm.202301-0177ED.

References
1.
Keller R, Gagne K, Usmani G, Asdourian G, Williams D, Hofmann I . CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer. 2012; 59(2):311-4. PMC: 3374040. DOI: 10.1002/pbc.24193. View

2.
Strikoudis A, Cieslak A, Loffredo L, Chen Y, Patel N, Saqi A . Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. Cell Rep. 2019; 27(12):3709-3723.e5. PMC: 6594401. DOI: 10.1016/j.celrep.2019.05.077. View

3.
Young L, Gulleman P, Short C, Tanjore H, Sherrill T, Qi A . Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI Insight. 2016; 1(17):e88947. PMC: 5070955. DOI: 10.1172/jci.insight.88947. View

4.
Nathan N, Giraud V, Picard C, Nunes H, Dastot-Le Moal F, Copin B . Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum Mol Genet. 2016; 25(8):1457-67. DOI: 10.1093/hmg/ddw014. View

5.
Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y . Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2011; 300(3):L391-401. PMC: 3284316. DOI: 10.1152/ajplung.00097.2010. View